Interviews with Authors
Our interviews with authors are also available as podcasts – listen here.
In conversation with Nicole Krentz - January 2023
Nicole Krentz talks to us about her recent paper: Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects endocrine cell gene expression by Katia K. Mattis, Nicole A. J. Krentz, Christoph Metzendorf, Fernando Abaitua, Aliya F. Spigelman, Han Sun, Jennifer M. Ikle, Swaraj Thaman, Antje K. Rottner, Austin Bautista, Eugenia Mazzaferro, Marta Perez-Alcantara, Jocelyn E. Manning Fox, Jason M. Torres, Agata Wesolowska-Andersen, Grace Z. Yu, Anubha Mahajan, Anders Larsson, Patrick E. MacDonald, Benjamin Davies, Marcel den Hoed & Anna L. Gloyn
In conversation with Ruizhi Zheng - November 2022
Ruizhi Zheng talks to us about his recent paper: Outdoor light at night in relation to glucose homoeostasis and diabetes in Chinese adults: a national and cross-sectional study of 98,658 participants from 162 study sites by Ruizhi Zheng, Zhuojun Xin, Mian Li, Tiange Wang, Min Xu, Jieli Lu, Meng Dai, Di Zhang, Yuhong Chen, Shuangyuan Wang, Hong Lin, Weiqing Wang, Guang Ning, Yufang Bi, Zhiyun Zhao & Yu Xu
In conversation with Svenja Meyhöfer - July 2022
Svenja Meyhöfer talks to us about her work on the effect of sleep deprivation on the counterregulatory response to recurrent hypoglycaemia.
In conversation with Wolfgang Rathmann - May 2022
Discussing recent Diabetologia paper: Incidence of newly diagnosed diabetes after Covid-19 by Wolfgang Rathmann, Oliver Kuss & Karel Kostev
In conversation with Patrick Schrauwen - November 2021
An interview with Professor Patrick Schrauwen regarding his recent research on the benefits of sitting less vs exercise for insulin sensitivity in a cohort of postmenopausal women.
In conversation with Mike Lean - October 2021
A discussion regarding remission in type 2 diabetes.
In conversation with Torben Hansen - July 2021
Our interview with author Torben Hansen about the research in a Greenlandic population cohort behind new publication: Physical activity attenuates postprandial hyperglycaemia in homozygous TBC1D4 loss-of-function mutation carriers Theresia M. Schnurr, Emil Jørsboe, Alexandra Chadt, Inger K. Dahl-Petersen, Jonas M. Kristensen, Jørgen F. P. Wojtaszewski, Christian Springer, Peter Bjerregaard, Søren Brage, Oluf Pedersen, Ida Moltke, Niels Grarup, Hadi Al-Hasani, Anders Albrechtsen, Marit E. Jørgensen & Torben Hansen
Dana Dabelea
Professor Dana Dabelea discusses her 2019 paper Developmental overnutrition and obesity and type 2 diabetes in offspring (10.1007/s00125-019-4914-1).
Management of hyperglycaemia in type 2 diabetes. 2018 EASD–ADA guidelines
Professors Melanie Davies and Chantal Mathieu discuss the 2018 EASD-ADA guidelines on the management of hyperglycaemia in type 2 diabetes (10.1007/s00125-018-4729-5).
Christoph Wanner
Professor Christoph Wanner talks about his 2018 Diabetologia paper on the future of SGLT2 inhibitors for the treatment of type 2 diabetes and other chronic diseases (10.1007/s00125-018-4678-z).
David Cherney and Merlin Thomas
Dr David Cherney and Dr Merlin Thomas discuss their 2018 Diabetologia paper on the actions of SGLT2 inhibitors on metabolism, renal function and blood pressure (10.1007/s00125-018-4669-0).
Gian Paolo Fadini
Professor Fadini discusses his 2017 Diabetologia paper on SGLT2 inhibitors and diabetic ketoacidosis (10.1007/s00125-017-4301-8).
Jordana Bell
Dr Jordana Bell discusses the importance of the human gut microbiome in diabetes.
Susanne Ullrich
Professor Susanne Ullrich discusses her 2017 Diabetologia paper 'Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion' (10.1007/s00125-017-4385-1).
Silvio Inzucchi
Professor Silvio Inzucchi discusses his 2018 Diabetologia paper weighing up the risks and benefits of the use of SGLT2 inhibitors in type 2 diabetes (10.1007/s00125-018-4663-6).
Nicolaas Schaper
Dr Nicolaas Schaper talks about his 2017 Diabetologia paper: Breaking sitting with light activities vs structured exercise: a randomised crossover study demonstrating benefits for glycaemic control and insulin sensitivity in type 2 diabetes (10.1007/s00125-016-4161-7).